Medifast (MED) Misses Q4 EPS by 2c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.08 -1.47%
EPS Growth %: -195.2%
Financial Fact:
Cost of sales: 16.42M
Today's EPS Names:
NEOV, MANU, CTAS, More
EPS Growth %: -195.2%
Financial Fact:
Cost of sales: 16.42M
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $2.36, $0.02 worse than the analyst estimate of $2.38. Revenue for the quarter came in at $264.9 million versus the consensus estimate of $244.49 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Jefferies Starts China Oilfield Services (A-Shares) (601808:CH) at Buy
- Meta bull case increasingly playing out, Mizuho says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
